ArticleProceedings of SPIE--the International Society for Optical Engineering2021
Comparison of skin dose calculated by the dose tracking system (DTS) with a beam angular correction factor and that calculated by Monte-Carlo.
Article in Proceedings of SPIE--the International Society for Optical Engineering, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Skin dose is dependent on the incident beam angle and corrections are needed for accurate estimation of the risk of deterministic effects of the skin. Angular-correction factors (ACF) were calculated and incorporated into our skin-dose-tracking system (DTS) and the results compared to Monte-Carlo simulations for a neuro-interventional procedure. To obtain the ACF's, EGSnrc Monte-Carlo (MC) software was used to calculate the dose averaged over 0.5, 1, 2, 3, 4 and 5 mm depth into the entrance surface of a water phantom at the center of the field as a function of incident beam to skin angle from 90-10 degrees for beam field sizes from 5-15 cm and for beam energies from 60-120 kVp. These values were normalized to the incident primary dose to obtain the ACF. The angle of incidence at each mesh vertex in the beam on the surface of the DTS patient graphic was calculated as the complement of the angle between the normal vector and the vector of the intersecting ray from the tube focal spot; skin dose at that vertex was calculated using the corresponding ACF. The skin-dose values with angular correction were compared to those calculated using MC with a matching voxelized phantom. The results show the ACF decreases with decreasing incident angle and skin thickness, and increases with increasing field size and kVp. Good agreement was obtained between the skin dose calculated by the angular-corrected DTS and MC, while use of the ACF allows the real-time performance of the DTS to be maintained.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.